login | register | order now | view cart | feedback
Stem Cell Research

Products >  Stem_Cell_Research >  Cells >  Human_Stem_Cell_Derived_Cardiomyocytes

Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells

Cellartis Cardiomyocytes are a highly homogenous population of cardiomyocytes derived from human induced pluripotent stem (iPS) cells (ChiPSC22). The iPS cells have been differentiated into spontaneously beating cardiomyocytes in vitro. These cells have been dissociated into a single cell suspension and frozen in vials. The Cellartis Cardiomyocytes (from ChiPSC22) Kit contains one vial of cardiomyocytes (>3 x 106 viable cells), one bottle of Cellartis CM thawing base, and one bottle of Cellartis CM Culture Base.

  At-A-Glance   Documents   Images & Data   Resources


  • Electrophysiological profile highly resembling adult human primary cardiomyocytes
  • Respond as expected to cardiac stimuli
  • Derived with a robust, efficient cardiac differentiation protocol, without genetic engineering or selection
  • Cells are provided with basal media for thawing and culture


  • Safety pharmacology
  • Cardiotoxicity testing
  • Discovery of novel cardiac drug targets
  • Phenotypic screening
  • High-content analysis (HCA)


  • 1 vial Cellartis Cardiomyocytes (>3 x 106 viable cells)
  • 1 bottle Cellartis CM Thawing Base (32 ml)
  • 1 bottle Cellartis CM Culture Base (90 ml)

Additional Product Information

Please see the product documents for information about storage conditions, product components, and technical specifications. Certificates of Analysis and User Manuals are located under the Documents tab.

Cat. # Product Contents Size Price License Units Select
Y10062 Cellartis® CM Thawing Base 32 mL $37.00  
Y10063 Cellartis® CM Culture Base 90 mL $83.00  
Y10075 Cellartis® Cardiomyocytes (from ChiPSC22) Kit 1 Kit $812.00 License Statements



Takara Bio USA is a Takara Bio Company © 2018 Privacy Policy | Terms & Conditions | Terms of Use